Genomic Health's Q1 Revenues Climb 17 Percent, Net Loss Turns to Profit | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health's first-quarter revenues rose 17 percent year over year, the company reported after the close of the market on Wednesday.

For the three months ended March 31, total revenues increased to $58.5 million, compared to $49.8 million for Q1 2011 and exceeding consensus analyst estimates of $56.3 million.

Product revenues, which make up most of the revenues, also increased 17 percent year over year to $57.9 million from $49.5 million, while contract revenues rose 60 percent to $563,000 from $352,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.